HOMA-IR for predicting clinical pregnancy rate during IVF

Gynecol Endocrinol. 2022 Jan;38(1):33-38. doi: 10.1080/09513590.2021.1952976. Epub 2021 Jul 15.

Abstract

Objective: To determine the cutoff values of HOMA-IR for predicting clinical pregnancy rate in normal weight patients during their first IVF.

Materials and methods: The data was retrospectively analyzed from 329 normal-weight women aged 21-40 years with BMI <25 kg/m2 who received first IVF-ET during the period from December 2018 to June 2019.We assessed the associations between HOMA-IR and clinical pregnancy rates during IVF in the women with or without PCOS according to different BMI ranges.

Results: In non PCOS,clinical pregnancy rate was significantly decreased at the HOMA-IR values ranging from 2.2 to 3.15 (OR, 0.188, 95% CI, 0.084-0.42; p < .05) and at those >3.15 (OR, 0.018, 95% CI, 0.004-0.081; p < .05).In PCOS, clinical pregnancy rate significantly decreased at the HOMA-IR >3.15 (OR, 0.15, 95% CI, 0.044-0.507; p < .05). In non PCOS with BMI <21.45 kg/m2, clinical pregnancy rate was decreased with HOMA-IR >2.2, and a significant cutoff point at HOMA-IR >3.15; with 21.45 ≤ BMI <25 kg/m2, clinical pregnancy rate was declined significantly at the HOMA-IR >1.56 (OR, 0.196, 95% CI, 0.055-0.704).In PCOS with BMI <21.45 kg/m2, clinical pregnancy rate was decreased as the HOMA-IR increased, but there was no significant cutoff point; with 21.45 ≤ BMI < 25 kg/m2, clinical pregnancy rate was declined significantly at the HOMA-IR > 3.15 (OR, 0.186; 95% CI, 0.04-0.872).

Conclusion: HOMA-IR and BMI had adverse effects on the IVF outcome of infertility women. Moreover, obesity can increase the degree of insulin resistance in infertility women. These findings suggested that only better HOMA-IR and BMI will lead to better IVF results.

Keywords: Homeostasis model assessment-insulin resistance; clinical pregancy rate; in vitro fertilization; insulin resistance.

MeSH terms

  • Adult
  • Body Mass Index
  • Female
  • Fertilization in Vitro*
  • Humans
  • Infertility, Female / therapy
  • Insulin Resistance / physiology*
  • Obesity / physiopathology
  • Polycystic Ovary Syndrome / physiopathology
  • Pregnancy
  • Pregnancy Rate*
  • Treatment Outcome